Intranasal glucagon VS injectable

Comparison of ease of use and acceptability of intranasal and injectable glucagon among providers administering it to children or adolescents with type 1 diabetes

Dr. Claudia Gagnon’s research laboratory, located at the Centre de recherche du CHU de Québec (CHUL site) – Université Laval, is looking for parents or guardians of children living with type 1 diabetes to participate in a research project. This is a simulation study of administration of intranasal glucagon compared to injectable glucagon after viewing short videos. You will then be invited to give your comments during an interview.

A financial compensation will be offered.


Participation consists of viewing three videos (approximately 6 minutes in total) and a single visit to Université Laval to participate in the simulated administration of injectable and intranasal glucagon as well as a short one-on-one interview.

Inclusion criteria

  • Parent or guardian of a child (<18 years old) living with type 1 diabetes
  • No repeated experiences in the administration of glucagon


If you are interested, contact the person responsible for the project at 418-525-4444 extension 48729 or write to the following email address: yue-pei.wang.1@ulaval.ca.